Shandong Sanyuan Biotechnology Co.Ltd. (301206) — Capital Reinvestment Ratio
Shandong Sanyuan Biotechnology Co.Ltd. (301206) has a Capital Reinvestment Ratio of 1.21x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥24.79 Million) in capital expenditures (CN¥29.92 Million). Check tangible equity quality of Shandong Sanyuan Biotechnology Co.Ltd. to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Sanyuan Biotechnology Co.Ltd. Capital Reinvestment Ratio (2013–2023)
This chart tracks Shandong Sanyuan Biotechnology Co.Ltd.'s Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Shandong Sanyuan Biotechnology Co.Ltd. (301206) cash flow conversion.
Annual Capital Reinvestment Ratio for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2023)
Year-by-year Capital Reinvestment Ratio for Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2023. See Shandong Sanyuan Biotechnology Co.Ltd. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 2.15x | CN¥57.31 Million | CN¥122.99 Million | ▼ -25.5% |
| 2022 | 2.88x | CN¥84.26 Million | CN¥242.67 Million | ▲ +325.7% |
| 2021 | 0.68x | CN¥642.08 Million | CN¥434.37 Million | ▼ -3.1% |
| 2020 | 0.70x | CN¥217.37 Million | CN¥151.76 Million | ▼ -26.0% |
| 2019 | 0.94x | CN¥149.21 Million | CN¥140.73 Million | ▲ +26.9% |
| 2018 | 0.74x | CN¥65.46 Million | CN¥48.65 Million | ▼ -68.2% |
| 2017 | 2.34x | CN¥20.25 Million | CN¥47.35 Million | ▲ +334.8% |
| 2016 | 0.54x | CN¥22.96 Million | CN¥12.35 Million | ▼ -45.8% |
| 2015 | 0.99x | CN¥9.50 Million | CN¥9.43 Million | ▼ -77.4% |
| 2014 | 4.40x | CN¥3.20 Million | CN¥14.05 Million | ▲ +1130.7% |
| 2013 | 0.36x | CN¥3.89 Million | CN¥1.39 Million | — |